Interview and Photo Opportunity at Finish Line: Novartis employees complete 600-km bike race today

• The annual Ride for Life ride raised close to $75,000 for breast cancer research

DORVAL, QC, Sept. 26, 2017 /CNW/ - Come cheer on 54 Novartis employees as they cross the finish line today after a 3.5 day, 600-kilometer charitable bike race that raised funds for the Quebec Breast Cancer Foundation (QBCF). The company's annual Ride for Life kicked off in Toronto on September 23^rd, making stops in Kingston and Ottawa before returning home to Montreal.

In Quebec, one out of nine women will develop breast cancer in the course of her lifetime and sadly, one out of 30 women will die from it.¹

What:	Photo and interview opportunity:
	Meet the riders at the finish line and speak to them about their experiences on this hard-fought journey Learn more about the work that the QBCF is doing to help support women in Quebec living with and affected by breast cancer as well as Novartis' commitment to those people living with the advanced form of the disease
Who:	Nathalie Tremblay, CEO, Quebec Breast Cancer Foundation
	Karen Iseult-Ippersiel, Vice-President of Business Development and Strategy, Quebec Breast Cancer Foundation
	Marie-Andrée Cyr, Ride for Life President, Oncology Business Unit, Novartis Pharmaceuticals Canada Inc.
	Winselow Tucker, General Manager, Oncology Business Unit, Novartis Pharmaceuticals Canada Inc.
Where:	Tuesday, September 26^th, 4:30 PM
When:	Ride for Life Cyclists Arrival Day Celebration & Closing Ceremony, Novartis Pharmaceuticals Canada Inc
	385 Bouchard Blvd., Dorval, Quebec.

*As part of the closing ceremony at Novartis, a cheque representing this year's proceeds will be presented to the QBCF.

About Ride for Life
Ride for Life^TM is an initiative launched in 2005 by Novartis employees wanting to help raise awareness and funds to the breast cancer community. Since 2005, Novartis has raised over $1 million dollars for the Quebec Breast Cancer Foundation, making them one of the largest fundraising teams in Quebec. To contribute to this cause or to learn more, please visit www.rubanrose.org/fundraising/activities/2017-ride-for-life.

About Novartis Pharmaceuticals Canada
Novartis Pharmaceuticals Canada Inc., a leader in the healthcare field, is committed to the discovery, development and marketing of innovative products to improve the well-being of all Canadians. In 2016, the company invested $48.8 million in research and development in Canada. Located in Dorval, Quebec, Novartis Pharmaceuticals Canada Inc. employs approximately 750 people in Canada and is an affiliate of Novartis AG, which provides innovative healthcare solutions that address the evolving needs of patients and societies. For further information, please consult www.novartis.ca.

References
¹ Canadian Breast Cancer Foundation. https://rubanrose.org/breast-cancer/understand/stats. Accessed on August 24, 2017.

SOURCE Novartis Pharmaceuticals Canada

Novartis Media Relations: Daphne Weatherby, Oncology Business Unit, Novartis Pharmaceuticals Canada Inc. Communications [phone], E-mail: [email protected]